ID   388F1
AC   CVCL_WL10
SY   HB 388F1
DR   CCRID; 4201PAT-CCTCC00111
DR   Wikidata; Q93305931
RX   Patent=US5565338;
RX   Patent=WO1994026923A1;
RX   PubMed=1730869;
RX   PubMed=7511819;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10472.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P14174; Human MIF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 6
//
RX   PubMed=7511819; DOI=10.1073/pnas.91.7.2824; PMCID=PMC43463;
RA   Gomi, Hideho
RA   Tagaya, Yutaka
RA   Nakano, Tatsumi
RA   Mikayama, Toshifumi
RA   Ishizaka, Kimishige
RT   "Antigen-binding glycosylation inhibiting factor from a human T-cell
RT   hybridoma specific for bee venom phospholipase A2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2824-2828(1994).
//
RX   Patent=WO1994026923A1;
RA   Ishizaka, Kimishige
RA   Liu, Yun-Cai
RA   Mikayama, Toshifumi
RT   "Method for recombinant production of biologically active
RT   polypeptides.";
RL   Patent number WO1994026923A1, 24-Nov-1994.
//
RX   Patent=US5565338;
RA   Ishizaka, Kimishige
RT   "Suppressor T-cell hybridoma and production of allergen specific
RT   glycosylation inhibiting factor.";
RL   Patent number US5565338, 15-Oct-1996.
//
RX   PubMed=1730869; DOI=10.4049/jimmunol.148.3.729;
RA   Thomas, Peter
RA   Gomi, Hideho
RA   Takeuchi, Toru
RA   Carini, Claudio
RA   Tagaya, Yutaka
RA   Ishizaka, Kimishige
RT   "Glycosylation-inhibiting factor from human T cell hybridomas
RT   constructed from peripheral blood lymphocytes of a bee venom-sensitive
RT   allergic patient.";
RL   J. Immunol. 148:729-737(1992).
//